I have heard from healthcare providers and patients that there is an added layer of difficulty in addressing shortages in this area because they say that the DEA limits the amount of active pharmaceutical ingredient a company can purchase and manufacture.
Engel discusses challenges in addressing drug shortages due to DEA regulations.
Share
More from Eliot Engel
H. Res. 697 is a strong measure that encourages the continuation of close engagement between the United States and Tibet. I reserve the balance of my time.
I reserve the balance of my time. Mr. McCAUL. Mr. Speaker, I yield 2 minutes to the gentleman from Illinois (Mr. Kinzinger).
I reserve the balance of my time. Mr. McCAUL. Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, in closing, I thank my friend and fellow Texan, Representative Conaway, who represents the family, for introducing this…
I once again thank Mr. Jeffries for authoring this important legislation. Mr. Speaker, I urge my colleagues on both sides of the aisle to support this legislation, and I yield back the balance of my time. The SPEAKER pro tempore. The…
Other voices in this conversation
